The Macular Degeneration Association (MDA) is currently accepting research grant proposals. We invite submissions that focus on age-related macular degeneration, dry macular degeneration, geographic atrophy, and/or diabetic macular edema. Our objective is to support innovative research that has the potential to lead to new treatments or cures for these conditions.
This proposal covers:
- Required submission information
- Exact form field wording
- Legal acknowledgements and disclaimers
- Reviewer scoring rubric
- Submission-to-decision workflow
- Technical implementation approach
- Purpose of the Initial Proposal Submission
The initial proposal submission serves as an intake and screening phase, not a final funding agreement.
At this stage, the Macular Degeneration Association seeks to determine:
- Scientific relevance to macular degeneration and related retinal diseases
- Feasibility of the proposed research
- Alignment with organizational mission
- Institutional readiness and compliance
Funding decisions are made within 30 days only after internal review and may require additional documentation prior to award.
Required Proposal Information
A. Principal Investigator Information
Form Fields (Exact Wording):
- Principal Investigator Full Name
- Academic Degrees (MD, PhD, OD, etc.)
- Professional Title
- Institutional Affiliation
- Department
- Institutional Address
- Email Address
- Phone Number
- ORCID iD (optional)
B. Project Overview
Form Fields:
- Project Title
- Research Area (dropdown)
- Dry AMD
- Wet AMD
- Geographic Atrophy
- Retinal Degeneration
- Diagnostics
- Treatment Innovation
- Other
- Project Abstract (250–500 words)
- Plain-Language Summary (for non-scientific audiences)
C. Scientific Description
Form Fields:
- Specific Aims (text or PDF upload)
- Background and Rationale (1–2 pages)
- Study Design and Methods
- Anticipated Outcomes
- Estimated Project Timeline